Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 3/20 | 0.58 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.58 |
| ▸ | PPARG | P37231 | 3/20 | 0.58 |
| ▸ | PPARD | Q03181 | 3/20 | 0.58 |
| ▸ | PPARA | Q07869 | 3/20 | 0.58 |
| ▸ | TOP1 | P11387 | 3/20 | 0.58 |
| ▸ | FAAH | O00519 | 3/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | BLM | P54132 | 2/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
| ▸ | FABP4 | P15090 | 2/20 | 0.58 |
| ▸ | F7 | P08709 | 2/20 | 0.58 |
| ▸ | F3 | P13726 | 2/20 | 0.58 |
| ▸ | GMNN | O75496 | 1/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5598319 | 1.00 | TERT (0.58) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL20529764 | 1.00 | TERT (0.58) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL7575667 | 1.00 | TERT (0.58) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL7575671 | 1.00 | TERT (0.58) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL20529758 | 0.98 | PPARG (0.55) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL7647197 | 0.98 | PPARG (0.55) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL20529741 | 0.94 | F7 (0.55) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL20529739 | 0.94 | F7 (0.55) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL12501477 | 0.86 | ALDH1A1 (0.41) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL12501476 | 0.86 | ALDH1A1 (0.41) | TERTPTPN1PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4359432-A2 | SHORT APOC-II MIMETIC PEPTIDES AND METHODS OF USE | The United States of America, as represented by The Secretary, Department of Health and Human Services (US) | 2024-05-01 | — | — | EP | claimed |
| WO-2023215838-A1 | SHORT APOLIPOPROTEIN E MIMETIC PEPTIDES AND METHODS OF USE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-11-09 | — | — | WO | claimed |
| CN-115811984-A | Antiviral structurally stable SARS-CoV-2 peptides and uses thereof | 丹娜法伯癌症研究院 | 2023-03-17 | — | — | CN | claimed |
| WO-2022271814-A2 | SHORT APOC-II MIMETIC PEPTIDES AND METHODS OF USE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2022-12-29 | — | — | WO | claimed |
| EP-3606940-A1 | STABLE MODULATORS OF GAMMA-C-CYTOKINE ACTIVITY | Bioniz, LLC (US) | 2020-02-12 | — | — | EP | claimed |
| CN-110506050-A | Stable modulators of gamma C cytokine activity | BIONIZ LLC | 2019-11-26 | — | — | CN | claimed |
| WO-2018187499-A1 | STABLE MODULATORS OF GAMMA-C-CYTOKINE ACTIVITY | BIONIZ, LLC (US) | 2018-10-11 | — | — | WO | claimed |
| US-12600757-B2 | Peptides inhibiting gamma-c-cytokine activity and methods of use | Bioniz Therapeutics, Inc. (US) | 2026-04-14 | — | — | US | disclosed |
| CN-119233984-A | Short apolipoprotein E mimetic peptides and methods of use thereof | 美国政府(由卫生和人类服务部的部长所代表) | 2024-12-31 | — | — | CN | disclosed |
| EP-4399220-A1 | ANTIVIRAL STRUCTURALLY-STAPLED SARS-COV-2 PEPTIDE- CHOLESTEROL CONJUGATES AND USES THEREOF | Dana-Farber Cancer Institute, Inc. (US) | 2024-07-17 | — | — | EP | disclosed |
| EP-4359432-A2 | SHORT APOC-II MIMETIC PEPTIDES AND METHODS OF USE | The United States of America, as represented by The Secretary, Department of Health and Human Services (US) | 2024-05-01 | — | — | EP | disclosed |
| CN-117580857-A | APOC-II short mimetic peptides and methods of use | 美国政府(由卫生和人类服务部的部长所代表) | 2024-02-20 | — | — | CN | disclosed |
| US-20230235301-A1 | Compounds and Methods for Treating, Ameliorating, or Preventing Herpes Ocular Keratitis | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2023-07-27 | — | — | US | disclosed |
| US-20210324029-A1 | STABLE MODULATORS OF GAMMA-C-CYTOKINE ACTIVITY | Bioniz Therapeutics, Inc. | 2021-10-21 | — | — | US | disclosed |
| WO-2021127493-A1 | STRUCTURALLY-STABILIZED GLUCAGON-LIKE PEPTIDE 1 PEPTIDES AND USES THEREOF | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2021-06-24 | — | — | WO | disclosed |
| EP-3606940-A1 | STABLE MODULATORS OF GAMMA-C-CYTOKINE ACTIVITY | Bioniz, LLC (US) | 2020-02-12 | — | — | EP | disclosed |
| CN-110506050-A | Stable modulators of gamma C cytokine activity | BIONIZ LLC | 2019-11-26 | — | — | CN | disclosed |
| EP-3423471-A1 | FUSION RESPIRATORY SYNCYTIAL VIRUS INHIBITORS AND USE THEREOF | Fondation The Ark (CH) | 2019-01-09 | — | — | EP | disclosed |
| WO-2018187499-A1 | STABLE MODULATORS OF GAMMA-C-CYTOKINE ACTIVITY | BIONIZ, LLC (US) | 2018-10-11 | — | — | WO | disclosed |
| WO-2017045080-A1 | FUNCTIONAL PROTEIN STRUCTURES AND METHODS OF MAKING AND USING SAME | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2017-03-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230235301-A1 | Compounds and Methods for Treating, Ameliorating, or Preventing Herpes Ocular Keratitis | STING1, TK1, PCNA | TERT 2404/4885PTPN1 4597/4885PPARG 3670/4885 |
| US-12600757-B2 | Peptides inhibiting gamma-c-cytokine activity and methods of use | IL15, IL2, IL15RA | TERT 2028/4885PTPN1 2146/4885PPARG 998/4885 |
| US-20210324029-A1 | STABLE MODULATORS OF GAMMA-C-CYTOKINE ACTIVITY | IL2, IL2RA, GMFG | TERT 3082/4885PTPN1 670/4885PPARG 1025/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.